Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Income Statement

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Income Statement

Last quarter (Q2 2026), Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s total revenue was zł12.85M, an increase of 104.47% from the same quarter last year. In Q2, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s net income was zł-2.76M. See Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s key income statements, including revenue, expenses, profit, and income.